| 6-Substituted hexamethylene amiloride (HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer BJ Buckley, A Aboelela, E Minaei, LX Jiang, Z Xu, U Ali, K Fildes, ... Journal of medicinal chemistry 61 (18), 8299-8320, 2018 | 60 | 2018 |
| Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer D Brungs, E Minaei, AK Piper, J Perry, A Splitt, M Carolan, S Ryan, XJ Wu, ... Scientific reports 10 (1), 539, 2020 | 36 | 2020 |
| Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer D Brungs, D Lynch, AWS Luk, E Minaei, M Ranson, M Aghmesheh, ... World journal of gastroenterology 24 (7), 810, 2018 | 25 | 2018 |
| N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines KL Vine, L Belfiore, L Jones, JM Locke, S Wade, E Minaei, M Ranson Heliyon 2 (1), 2016 | 23 | 2016 |
| 6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease BJ Buckley, H Majed, A Aboelela, E Minaei, L Jiang, K Fildes, CY Cheung, ... Bioorganic & medicinal chemistry letters 29 (24), 126753, 2019 | 21 | 2019 |
| Cancer progression gene expression profiling identifies the urokinase plasminogen activator receptor as a biomarker of metastasis in cutaneous squamous cell carcinoma E Minaei, SA Mueller, B Ashford, AS Thind, J Mitchell, JR Perry, ... Frontiers in oncology 12, 835929, 2022 | 12 | 2022 |
| Comprehensive mutational and phenotypic characterization of new metastatic cutaneous squamous cell carcinoma cell lines reveal novel drug susceptibilities J Perry, B Ashford, AS Thind, ME Gauthier, E Minaei, G Major, NG Iyer, ... International Journal of Molecular Sciences 21 (24), 9536, 2020 | 11 | 2020 |
| Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma AS Thind, B Ashford, D Strbenac, J Mitchell, J Lee, SA Mueller, E Minaei, ... Frontiers in oncology 12, 919118, 2022 | 8 | 2022 |
| Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma TJ Eviston, E Minaei, SA Mueller, N Ahmadi, B Ashford, JR Clark, N West, ... Scientific Reports 11 (1), 13192, 2021 | 8 | 2021 |
| Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma J Perry, E Minaei, E Engels, BG Ashford, L McAlary, JR Clark, R Gupta, ... Physics in Medicine & Biology 65 (21), 215018, 2020 | 7 | 2020 |
| PO-437 Drug and radio sensitivity profile of a primary CTC cell line derived from a patient with metastatic neuroendocrine tumour of the distal oesophagus E Minaei, D Brungs, E Engels, KL Vine, M Tehei, S Corde, M Ranson ESMO Open 3, A402-A403, 2018 | 1 | 2018 |
| OPEN ACCESS EDITED BY G Chhabra, T Ito, S Su, AS Thind, B Ashford, D Strbenac¹, J Mitchell, J Lee, ... Prognostic Gene Signatures in Skin Cancer, 159, 2023 | | 2023 |
| Non-coding and coding genomic mutational drivers of metastatic cutaneous squamous cell carcinoma AS Thind, B Ashford, D Strbenac, R Gupta, J Clark, NG Iyer, E Minaei, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 34-35, 2021 | | 2021 |
| Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma JR Perry, AS Thind, E Minaei, E Ryan, B Genenger, G Iyer, C Martin, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 43-43, 2021 | | 2021 |
| The role of urokinase plasminogen activator receptor in HNcSCC progression and metastasis E Minaei, SA Mueller, AS Thind, B Ashford, J Perry, J Clark, R Gupta, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 34-34, 2021 | | 2021 |
| P-115 The potential of panel-based gene expression analysis in the identification of head and neck cutaneous squamous cell carcinoma with high risk of lymph node metastasis SA Mueller, E Minaei, B Ashford, J Perry, JR Clark, R Gupta, M Ranson Oral Oncology 118, 2, 2021 | | 2021 |
